{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:04:50Z","timestamp":1789034690134,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.thromres.2023.06.031","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T15:04:56Z","timestamp":1688223896000},"page":"53-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Repurposing of rilpivirine for preventing platelet \u03b23 integrin-dependent thrombosis by targeting c-Src active autophosphorylation"],"prefix":"10.1016","volume":"229","author":[{"given":"Kui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyisha","family":"Tuerhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.thromres.2023.06.031_bb0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","article-title":"Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease","volume":"118","author":"Herrington","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.thromres.2023.06.031_bb0010","first-page":"1","article-title":"Flavonoids as potential anti-platelet aggregation agents: from biochemistry to health promoting abilities","author":"Sharifi-Rad","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"7","key":"10.1016\/j.thromres.2023.06.031_bb0015","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/cvr\/cvz070","article-title":"Platelets in cardiac ischaemia\/reperfusion injury: a promising therapeutic target","volume":"115","author":"Ziegler","year":"2019","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.thromres.2023.06.031_bb0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","article-title":"Platelet biology and functions: new concepts and clinical perspectives","volume":"16","author":"van der Meijden","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"14","key":"10.1016\/j.thromres.2023.06.031_bb0025","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood-2017-03-773614","article-title":"Integrin \u03b1IIb\u03b23 outside-in signaling","volume":"130","author":"Durrant","year":"2017","journal-title":"Blood."},{"issue":"8","key":"10.1016\/j.thromres.2023.06.031_bb0030","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1182\/blood-2008-06-077891","article-title":"The GPIIb\/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend","volume":"112","author":"Coller","year":"2008","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.thromres.2023.06.031_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/ATVBAHA.114.303411","article-title":"Targeting integrin and integrin signaling in treating thrombosis","volume":"35","author":"Estevez","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"40","key":"10.1016\/j.thromres.2023.06.031_bb0040","doi-asserted-by":"crossref","first-page":"29426","DOI":"10.1074\/jbc.C600039200","article-title":"Tyrosine phosphorylation of the integrin beta 3 subunit regulates beta 3 cleavage by calpain","volume":"281","author":"Xi","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.thromres.2023.06.031_bb0045","doi-asserted-by":"crossref","first-page":"12623","DOI":"10.1074\/jbc.273.20.12623","article-title":"Distinct involvement of beta3 integrin cytoplasmic domain tyrosine residues 747 and 759 in integrin-mediated cytoskeletal assembly and phosphotyrosine signaling","volume":"273","author":"Schaffner-Reckinger","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.thromres.2023.06.031_bb0050","doi-asserted-by":"crossref","first-page":"13878","DOI":"10.1074\/jbc.273.22.13878","article-title":"Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions","volume":"273","author":"Jenkins","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.thromres.2023.06.031_bb0055","doi-asserted-by":"crossref","first-page":"13298","DOI":"10.1073\/pnas.2336149100","article-title":"Src kinase activation by direct interaction with the integrin beta cytoplasmic domain","volume":"100","author":"Arias-Salgado","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 2","key":"10.1016\/j.thromres.2023.06.031_bb0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1242\/jcs.018093","article-title":"Integrin signalling at a glance","volume":"122","author":"Harburger","year":"2009","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.thromres.2023.06.031_bb0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1083\/jcb.200112113","article-title":"Coordinate interactions of Csk, Src, and Syk kinases with \u03b1IIb\u03b23 initiate integrin signaling to the cytoskeleton","volume":"157","author":"Obergfell","year":"2002","journal-title":"J. Cell Biol."},{"issue":"13","key":"10.1016\/j.thromres.2023.06.031_bb0070","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2014-01-453134","article-title":"Src family kinases: at the forefront of platelet activation","volume":"124","author":"Senis","year":"2014","journal-title":"Blood."},{"issue":"14","key":"10.1016\/j.thromres.2023.06.031_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012241","article-title":"HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database","volume":"8","author":"Alonso","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"7","key":"10.1016\/j.thromres.2023.06.031_bb0080","first-page":"886","article-title":"Cardiovascular disease among people living with HIV in Brazil","volume":"25","author":"Boettiger","year":"2020"},{"issue":"18","key":"10.1016\/j.thromres.2023.06.031_bb0085","article-title":"HIV infection and the risk of World Health Organization\u2013Defined Sudden Cardiac Death","volume":"10","author":"Freiberg","year":"2021"},{"issue":"4","key":"10.1016\/j.thromres.2023.06.031_bb0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40256-020-00451-9","article-title":"Coronary artery disease in patients with HIV infection: an update","volume":"21","author":"Patel","year":"2021","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"2","key":"10.1016\/j.thromres.2023.06.031_bb0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-0038-1676374","article-title":"Pathological clotting and deep vein thrombosis in patients with HIV","volume":"45","author":"Jackson","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2023.06.031_bb0100","doi-asserted-by":"crossref","first-page":"ehw583","DOI":"10.1093\/eurheartj\/ehw583","article-title":"Platelet reactivity inhuman immunodeficiency virusinfected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study","author":"Hauguel-Moreau","year":"2017","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.thromres.2023.06.031_bb0105","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/CIRCRESAHA.119.316477","article-title":"HIV antivirals affect endothelial activation and endothelial-platelet crosstalk","volume":"127","author":"Khawaja","year":"2020","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.thromres.2023.06.031_bb0110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2165\/11208590-000000000-00000","article-title":"Rilpivirine","volume":"72","author":"Sanford","year":"2012","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.thromres.2023.06.031_bb0115","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1016\/S2352-3018(21)00184-3","article-title":"Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study","volume":"8","author":"Orkin","year":"2021","journal-title":"Lancet HIV"},{"issue":"11","key":"10.1016\/j.thromres.2023.06.031_bb0120","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1016\/S2352-3018(21)00185-5","article-title":"Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study","volume":"8","author":"Jaeger","year":"2021","journal-title":"Lancet HIV"},{"issue":"10","key":"10.1016\/j.thromres.2023.06.031_bb0125","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1093\/jac\/dkv195","article-title":"A randomized, controlled trial of the effect of rilpivirine versus efavirenz on cardiovascular risk in healthy volunteers","volume":"70","author":"Gupta","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.thromres.2023.06.031_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3268-5","article-title":"Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)","volume":"18","author":"Taramasso","year":"2018","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.thromres.2023.06.031_bb0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/15284336.2015.1112480","article-title":"Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia","volume":"17","author":"Thamrongwonglert","year":"2016","journal-title":"HIV Clin. Trials"},{"issue":"7","key":"10.1016\/j.thromres.2023.06.031_bb0140","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.apsb.2021.01.008","article-title":"A novel PGAM5 inhibitor LFHP-1c protects blood-brain barrier integrity in ischemic stroke","volume":"11","author":"Gao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.thromres.2023.06.031_bb0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.thromres.2023.06.031_bb0150","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1021\/acs.jcim.9b00332","article-title":"D3Pockets: a method and web server for systematic analysis of protein pocket dynamics","volume":"59","author":"Chen","year":"2019","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.thromres.2023.06.031_bb0155","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.apsb.2020.11.002","article-title":"A novel SIRT6 activator ameliorates neuroinflammation and ischemic brain injury via EZH2\/FOXC1 axis","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.thromres.2023.06.031_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105640","article-title":"Medioresinol as a novel PGC-1alpha activator prevents pyroptosis of endothelial cells in ischemic stroke through PPARalpha-GOT1 axis","volume":"169","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.thromres.2023.06.031_bb0165","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/gutjnl-2019-318372","article-title":"Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells","volume":"69","author":"Mart\u00ed-Rodrigo","year":"2020","journal-title":"Gut."},{"issue":"4","key":"10.1016\/j.thromres.2023.06.031_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-04789-7","article-title":"Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is less","volume":"13","author":"Lucantoni","year":"2022","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.thromres.2023.06.031_bb0175","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","article-title":"A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse","volume":"107","author":"Gao","year":"2010","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.thromres.2023.06.031_bb0180","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1097\/INF.0000000000001214","article-title":"Rilpivirine pharmacokinetics without and with darunavir\/ritonavir once daily in adolescents and young adults","volume":"35","author":"Foca","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"3","key":"10.1016\/j.thromres.2023.06.031_bb0185","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/rth2.12495","article-title":"Platelet Src family kinases: a tale of reversible phosphorylation","volume":"5","author":"Senis","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"02","key":"10.1016\/j.thromres.2023.06.031_bb0190","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0037-1613694","article-title":"Thromboinflammatory functions of platelets in ischemia\u2013reperfusion injury and its dysregulation in diabetes","volume":"44","author":"Yuan","year":"2018","journal-title":"Semin. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.thromres.2023.06.031_bb0195","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cardiores.2003.11.036","article-title":"Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium","volume":"61","author":"Gawaz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2023.06.031_bb0200","first-page":"10","article-title":"Platelet contributions to myocardial ischemia\/reperfusion injury","author":"Schanze","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.thromres.2023.06.031_bb0205","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.thromres.2023.06.031_bb0210","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1021\/acs.jmedchem.8b00843","article-title":"The journey of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) from lab to clinic","volume":"62","author":"Namasivayam","year":"2018","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.thromres.2023.06.031_bb0215","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/jac\/dkw125","article-title":"Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans","volume":"71","author":"Hohmann","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.thromres.2023.06.031_bb0220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10735-019-09826-y","article-title":"Rilpivirine as a potential candidate for the treatment of HIV-associated neurocognitive disorders (HAND)","volume":"50","author":"Ntshangase","year":"2019","journal-title":"J. Mol. Histol."},{"issue":"5","key":"10.1016\/j.thromres.2023.06.031_bb0225","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ijantimicag.2013.01.004","article-title":"Potential of the novel antiretroviral drug rilpivirine to modulate the expression and function of drug transporters and drug-metabolising enzymes in vitro","volume":"41","author":"Weiss","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"25","key":"10.1016\/j.thromres.2023.06.031_bb0230","doi-asserted-by":"crossref","first-page":"15825","DOI":"10.1074\/jbc.M115.648428","article-title":"The tyrosine kinase c-Src specifically binds to the active integrin \u03b1IIb\u03b23 to initiate outside-in signaling in platelets","volume":"290","author":"Wu","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.thromres.2023.06.031_bb0235","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bbrc.2004.09.171","article-title":"Src protein\u2013tyrosine kinase structure and regulation","volume":"324","author":"Roskoski","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.thromres.2023.06.031_bb0240","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-015-0159-8","article-title":"Evaluation of targeting c-Src by the RGT-containing peptide as a novel antithrombotic strategy","volume":"8","author":"Huang","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.thromres.2023.06.031_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2005.03.012","article-title":"Src kinase regulation by phosphorylation and dephosphorylation","volume":"331","author":"Roskoski","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.thromres.2023.06.031_bb0250","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/jth.14335","article-title":"Platelet Shp2 negatively regulates thrombus stability under high shear stress","volume":"17","author":"Hu","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2023.06.031_bb0255","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1074-5521(99)80118-5","article-title":"Structural basis for selective inhibition of Src family kinases by PP1","volume":"6","author":"Liu","year":"1999","journal-title":"Chem. Biol."},{"issue":"1\u20133","key":"10.1016\/j.thromres.2023.06.031_bb0260","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-5793(03)00069-3","article-title":"The pp60c-Srcinhibitor PP1 is non-competitive against ATP","volume":"537","author":"Karni","year":"2003","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.thromres.2023.06.031_bb0265","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1182\/blood-2008-09-180604","article-title":"Tyrosine kinase inhibitor\u2013induced platelet dysfunction in patients with chronic myeloid leukemia","volume":"114","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Blood."},{"issue":"7","key":"10.1016\/j.thromres.2023.06.031_bb0270","doi-asserted-by":"crossref","first-page":"2103228","DOI":"10.1002\/advs.202103228","article-title":"Targeting the RT loop of Src SH3 in platelets prevents thrombosis without compromising hemostasis","volume":"9","author":"Mao","year":"2022","journal-title":"Adv. Sci."},{"issue":"8","key":"10.1016\/j.thromres.2023.06.031_bb0275","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood.2019002314","article-title":"The 14-3-3zeta-c-Src-integrin-beta3 complex is vital for platelet activation","volume":"136","author":"Shen","year":"2020","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.thromres.2023.06.031_bb0280","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/CIRCRESAHA.114.302670","article-title":"Growth factor receptor-bound protein 2 contributes to (hem)immunoreceptor tyrosine-based activation motif-mediated signaling in platelets","volume":"114","author":"Dutting","year":"2014","journal-title":"Circ. Res."},{"issue":"18","key":"10.1016\/j.thromres.2023.06.031_bb0285","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/01.CIR.0000146341.63677.3C","article-title":"Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy","volume":"110","author":"Gruner","year":"2004","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.thromres.2023.06.031_bb0290","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1160\/TH07-07-0479","article-title":"Real-time measurement of non-lethal platelet thromboembolic responses in the anaesthetized mouse","volume":"99","author":"Tymvios","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2023.06.031_bb0295","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1016\/S2352-3018(16)30113-8","article-title":"Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment","volume":"3","author":"McGowan","year":"2016","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.thromres.2023.06.031_bb0300","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41467-017-02294-6","article-title":"Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy","volume":"9","author":"Kirtane","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.thromres.2023.06.031_bb0305","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2018.11.002","article-title":"Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension","volume":"292","author":"Mc Crudden","year":"2018","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.thromres.2023.06.031_bb0310","first-page":"1112","article-title":"Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression","volume":"382","author":"Swindells","year":"2020"},{"issue":"4","key":"10.1016\/j.thromres.2023.06.031_bb0315","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/COH.0000000000000474","article-title":"Rilpivirine long-acting for the prevention and treatment of HIV infection","volume":"13","author":"Ferretti","year":"2018","journal-title":"Curr. Opin. HIV AIDS"}],"updated-by":[{"DOI":"10.1016\/j.thromres.2024.109198","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000}}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T01:25:17Z","timestamp":1730251517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823002128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":63,"alternative-id":["S0049384823002128"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.06.031","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.thromres.2024.109198","asserted-by":"object"}]},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of rilpivirine for preventing platelet \u03b23 integrin-dependent thrombosis by targeting c-Src active autophosphorylation","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}